1. Bouhassira D. Neuropathic pain: Definition, assessment and epidemiology. Revue Neurologique, 2019, vol. 175, no. 1-2, pp. 16-25. https://doi.org/10.1016/j.neurol.2018.09.016
2. Murnion B. P. Neuropathic pain: current definition and review of drug treatment. Australian Prescribers, 2018, vol. 41, no. 3, pp. 60-63. https://doi.org/10.18773/austprescr.2018.022
3. Smith B. H., Hébert H. L., Veluchamy A. Neuropathic pain in the community: prevalence, impact, and risk factors. Pain, 2020, vol. 161, suppl. 1, pp. S127-S137. https://doi.org/10.1097/j.pain.0000000000001824
4. Han Y., Li X., Zhang Y., Han Yu., Chang F., Ding J. Mesenchymal stem cells for regenerative medicine. Cells, 2019, vol. 8, no. 8, art. 886. https://doi.org/10.3390/cells8080886
5. Melief S. M., Zwaginga J. J., Fibbe W. E., Roelofs H. Adipose tissue derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Translational Medicine, 2013, vol. 2, no. 6, pp. 455-463. https://doi.org/10.5966/sctm.2012-0184
6. Harrell C. R., Fellabaum C., Jovicic N., Djonov V., Arsenijevic N., Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells, 2019, vol. 8, no. 5, pp. 467-501. https://doi.org/10.3390/cells8050467
7. Zhou Y., Yamamoto Y., Xiao Z., Ochiya T. The immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity. Journal of Clinical Medicine, 2019, vol, 12, no. 8, pp. 1025‒1042. https://doi.org/10.3390/jcm8071025
8. Mert T., Kurt A. H., Arslan M., Çelik A., Tugtag B., Akkurt A. Anti-inflammatory and anti-nociceptive actions of systemically or locally treated adipose-derived mesenchymal stem cells in experimental inflammatory model. Inflammation, 2015, vol. 38, no. 3, pp. 1302‒1310. https://doi.org/10.1007/s10753-014-0101-1
9. Erofeeva A.-M. V., Zhavoronok I. P., Antipova O. A., Ryzhkovskaya E. L., Kuznetsova T. E., Vasilevich I. B., Pinchuk S. V., Volotovskii I. D., Molchanova A. Yu. Effects of adipose-derived mesenchymal stem cells on nociceptive sensitivity and repair processes at Achilles tendon injury model in rats. Doklady Natsional’noi akademii nauk Belarusi = Doklady of the National Academy of Sciences of Belarus, 2020, vol. 64, no. 5, pp. 574-582 (in Russian).
10. Pinchuk S. V., Molchanova A. Yu., Vasilevich I. B., Zhavoronok I. P., Pekhtereva E. I., Antipova O. A., Zalutskii I. V., Volotovskii I. D. Use of hemostatic drug Spongostan as a carrier of mesenchymal stem cells in the treatment of experimental urinary incontinence in rats. Doklady Natsional’noi akademii nauk Belarusi = Doklady of the National Academy of Sciences of Belarus, 2019, vol. 63, no. 4, pp. 457-465 (in Russian).
11. Deuis J. R., Dvorakova L. S., Vetter I. Methods used to evaluate pain behaviors in rodents. Frontiers in Molecular Neuroscience, 2017, vol. 10, art. 284. https://doi.org/10.3389/fnmol.2017.00284
12. Chicheva M. M., Vikhareva E. V., Mal’tsev A. V., Ustyugov A. A. Evolution of methods for assessing the motor function of laboratory rodents ‒ neurodegenerative diseases models. Biomedical Chemistry: Research and Methods, 2018, vol. 1, no. 3, p. e00030 (in Russian).
13. Bain J. R., Mackinnon S. E., Hunter R. T. Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plastic and Reconstructive Surgery, 1989, vol. 83, no. 1, pp. 129-136. https://doi.org/10.1097/00006534-198901000-00024